Clinicians need critical diagnostics earlier to empower the best, actionable care pathways.
Empowered clinicians give millions the opportunity of timely treatment and improved patient outcomes.
Is to bring trusted diagnostics to the point of initial patient interaction, to expand access of quality healthcare to new settings, no matter where that patient interaction occurs
Timely Host Response Diagnostics for SEPSIS and Pneumonia
*The Nanōmix eLab® S1 Panel for Critical Infection has received CE Mark; other assays in development and regulatory review.
Critical Host Response Diagnostics in Minutes. Hand-held, Multiplex Immunoassay from a Single Sample.
Study incorporates the use of the Nanōmix eLab® S1 Panel within the Emergency Department of Hospital Clinico San Carlos in Madrid, Spain
IVDR certification enables Nanōmix to market its eLab® analyzer in the European Union under the newly established regulatory guidelines
We are very pleased to report CE mark designation in Europe for our S1 assay panel using a whole blood sample type
Upgrading to the OTCQB is a timely and important milestone for Nanōmix, as we continue to commercialize our Nanōmix eLab® system, a mobile point-of-care diagnostic testing platform.
